Evidence map›Paper›PMID 39093451›Full record

ArticleCancer immunology, immunotherapy : CII2024

Highlighting immune features of the tumor ecosystem and prognostic value of Tfh and Th17 cell infiltration in head and neck squamous cell carcinoma by single-cell RNA-seq.

Yan Tian, Chao Liu, Wenhui Yang, Xiaohui Li, Min Zhang, Yan Xiong, Xueying Ren, Zhiguo Ma, Xuan Jin, Yanping Wu and 5 more

Abstract read
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yan TianDepartment of Medical Oncology, Peking University First Hospital, Beijing, China.
Chao LiuDepartment of Radiation Oncology, Peking University First Hospital, Beijing, China.
Wenhui YangDepartment of Oncology, Renmin Hospital of Wuhan University, Wuhan, China.
Xiaohui LiDepartment of Medical Oncology, Peking University First Hospital, Beijing, China.
Min ZhangDepartment of Radiation Oncology, Peking University People's Hospital, Beijing, China.
Yan XiongDepartment of Pathology, Peking University First Hospital, Beijing, China.
Xueying RenDepartment of Radiation Oncology, Peking University First Hospital, Beijing, China.
Zhiguo MaDepartment of Neurology, Xi' an Aerospace General Hospital, Xian, China.
Xuan JinDepartment of Medical Oncology, Peking University First Hospital, Beijing, China.
Yanping WuDepartment of Medical Oncology, Peking University First Hospital, Beijing, China.
Xin DongDepartment of Medical Oncology, Peking University First Hospital, Beijing, China.
Nanlin HuDepartment of Medical Oncology, Peking University First Hospital, Beijing, China.
Zhijun XieDepartment of Medical Oncology, Peking University First Hospital, Beijing, China.
Yong QinDepartment of Otolaryngology Head and Neck Surgery, Peking University First Hospital, Beijing, China. youngcaptain@sina.com.
Shikai WuDepartment of Medical Oncology, Peking University First Hospital, Beijing, China. skywu4923@sina.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHead and neck squamous cell carcinoma (HNSCC) typically present with a complex anatomical distribution, often accompanied by insidious symptoms. This combination contributes to its high incidence and poor prognosis. It is now understood that the immune features of cellular components within the tumor ecosystem and their complex interactions are critical factors influencing both tumor progression and the effective immune response.

methodsWe obtained single-cell RNA sequencing data of 26,496 cells from three tumor tissues and five normal tissues and performed subsequent analyses. Immunohistochemical staining on tumor sections was used to validate the presence of malignant cells. Additionally, we included bulk RNA sequencing data from 502 HNSCC patients. Kaplan-Meier analysis and the log-rank test were employed to assess predictors of patient outcomes.

resultsWe identified three epithelial subclusters exhibiting immune-related features. These subclusters promoted the infiltration of T cells, dendritic cells, and monocytes into the tumor microenvironment. Additionally, cancer-associated fibroblasts displayed tumor-promoting and angiogenesis characteristics, contrasting with the predominant antigen-presenting and inflammatory roles observed in fibroblasts from normal tissues. Furthermore, tumor endothelial subsets exhibited a double-sided effect, promoting tumor progression and enhancing the effectiveness of immune response. Finally, follicular helper T cells and T helper 17 cells were found to be significantly correlated with improved outcomes in HNSCC patients. These CD4

conclusionOur findings provide deeper insights into the immune features of the tumor ecosystem and reveal the prognostic significance of follicular helper T cells and T helper 17 cells. These findings may pave the way for the development of therapeutic approaches.

Indexed as

Head and Neck NeoplasmsLymphocytes, Tumor-InfiltratingSingle-Cell Gene Expression AnalysisSquamous Cell Carcinoma of Head and NeckTh17 CellsTumor MicroenvironmentFemaleHumansMalePrognosisRNA-SeqT Follicular Helper CellsHead and neck cancerImmune responsePrognosisSingle-cell sequencingTumor microenvironment

Identifiers

PMID39093451
PMCPMC11297013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.